For: | Long HY, Huang TY, Xie XY, Long JT, Liu BX. Treatment strategies for hepatocellular carcinoma with extrahepatic metastasis. World J Clin Cases 2021; 9(21): 5754-5768 [PMID: 34368295 DOI: 10.12998/wjcc.v9.i21.5754] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v9/i21/5754.htm |
Number | Citing Articles |
1 |
Hao-Huan Tang, Ming-Qing Zhang, Zi-Chen Zhang, Chen Fan, Yong Jin, Wei-Dong Wang. The Safety and Efficacy of Hepatic Arterial Infusion Chemotherapy Combined with PD-(L)1 Inhibitors and Molecular Targeted Therapies for the Treatment of Intermediate and Advanced Hepatocellular Carcinoma Unsuitable for Transarterial Chemoembolization. Journal of Hepatocellular Carcinoma 2023; : 2211 doi: 10.2147/JHC.S441024
|
2 |
Jason K. Wong, Howard J. Lim, Vincent C. Tam, Kelly W. Burak, Laura A. Dawson, Prosanto Chaudhury, Robert J. Abraham, Brandon M. Meyers, Gonzalo Sapisochin, David Valenti, Setareh Samimi, Ravi Ramjeesingh, Amol Mujoomdar, Ilidio Martins, Elijah Dixon, Maja Segedi, David M. Liu. Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in Canada. Cancer Treatment Reviews 2023; 115: 102526 doi: 10.1016/j.ctrv.2023.102526
|
3 |
Tinotenda Blessing Madzikatire, Yunfeng Shan. Case report and literature analysis: solitary HCC- recurrence in the right maxillary sinus after curative resection. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1279126
|
4 |
Wen-Bin Duan, Xiao-Hui Wang, Guo-Can Zhang, Zhuo He, Shao-Qiang Li, Jie Zhou. Efficacy of Lenvatinib Combined with PD-1 Inhibitor versus Sorafenib and PD-1 Inhibitor with or Without TACE for Hepatocellular Carcinoma with Extrahepatic Metastasis. ImmunoTargets and Therapy 2024; : 247 doi: 10.2147/ITT.S452339
|
5 |
Byeong Geun Song, Myung Ji Goh, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Moon Seok Choi. Role of transarterial chemoembolization for hepatocellular carcinoma with extrahepatic metastases in the era of advancing systemic therapy. Journal of Liver Cancer 2024; 24(2): 243 doi: 10.17998/jlc.2024.05.26
|
6 |
Ch. Paganetti, A. Heigl, R. Rosenberg, M. Vetter, J. Haslbauer, M. Steuerwald. Case report: 65-year-old man with metachronous left sided adrenal metastasis of hepatocellular carcinoma. International Journal of Surgery Case Reports 2024; 119: 109683 doi: 10.1016/j.ijscr.2024.109683
|
7 |
Leonardo Gomes da Fonseca, Raphael L C Araujo. Combination approaches in hepatocellular carcinoma: How systemic treatment can benefit candidates to locoregional modalities. World Journal of Gastroenterology 2022; 28(28): 3573-3585 doi: 10.3748/wjg.v28.i28.3573
|
8 |
Rocchina Miglionico, Ilenia Matera, Giovanna Maria Ventola, Giovanna Marchese, Vittorio Abruzzese, Magnus Monné, Angela Ostuni, Faustino Bisaccia. Gene Expression Reprogramming by Citrate Supplementation Reduces HepG2 Cell Migration and Invasion. International Journal of Molecular Sciences 2024; 25(12): 6509 doi: 10.3390/ijms25126509
|
9 |
Reena Gupta, Mustafa M. Kadhim, Abduladheem Turki Jalil, Ali Mohammed Obayes, Zafar Aminov, Fahad Alsaikhan, Andrés Alexis Ramírez-Coronel, Pushpamala Ramaiah, Nahla A. Tayyib, Xuanming Luo. Multifaceted role of NF-κB in hepatocellular carcinoma therapy: Molecular landscape, therapeutic compounds and nanomaterial approaches. Environmental Research 2023; 228: 115767 doi: 10.1016/j.envres.2023.115767
|
10 |
Junjun Jia, Jia Luo, Bei Zou, Meibao Feng, Li Liu, Songfeng Yu, Shusen Zheng, Jun Yu. Non-iatrogenic implantation of cutaneous metastasis from hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2023; 149(4): 1513 doi: 10.1007/s00432-022-04030-0
|